These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Stroke prevention in atrial fibrillation: WATCHMAN versus warfarin. Holmes DR; Fountain R Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):727-9. PubMed ID: 19589108 [No Abstract] [Full Text] [Related]
4. Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device. Möbius-Winkler S; Schuler GC; Sick PB Curr Opin Neurol; 2008 Feb; 21(1):64-9. PubMed ID: 18180653 [TBL] [Abstract][Full Text] [Related]
5. Newer anticoagulants as an alternate to warfarin in atrial fibrillation: a changing paradigm. Chaudhari D; Bhuriya R; Arora R Am J Ther; 2011 Jan; 18(1):e1-e11. PubMed ID: 20460986 [TBL] [Abstract][Full Text] [Related]
6. [The BAFTA study]. Di Pasquale G; Palareti G G Ital Cardiol (Rome); 2008 Nov; 9(11):735-9. PubMed ID: 19058663 [No Abstract] [Full Text] [Related]
7. Warfarin: is the end nigh? Please? Neilson RF J R Coll Physicians Edinb; 2010 Sep; 40(3):222-3. PubMed ID: 21127766 [No Abstract] [Full Text] [Related]
8. Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation. Liew A; Eikelboom JW; O'Donnell M Curr Opin Cardiol; 2012 Jul; 27(4):331-9. PubMed ID: 22573171 [TBL] [Abstract][Full Text] [Related]
9. Which patients with atrial fibrillation do not need anticoagulation therapy with warfarin? Guthmann RA Am Fam Physician; 2004 Sep; 70(5):917-8. PubMed ID: 15368730 [No Abstract] [Full Text] [Related]
10. A novel approach to left atrial appendage exclusion: the WATCHMAN device. Gorodnitskiy A; Lucariello RJ; Aizer A; Coppola JT Cardiol Rev; 2010; 18(5):230-3. PubMed ID: 20699670 [TBL] [Abstract][Full Text] [Related]
12. New device for stroke prevention in atrial fibrillation as an alternative to anticoagulation drugs. Lobodzinski SS Cardiol J; 2009; 16(4):375-8. PubMed ID: 19653186 [No Abstract] [Full Text] [Related]
13. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583 [TBL] [Abstract][Full Text] [Related]
14. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?]. Selçuk H; Selçuk MT; Maden O Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079 [TBL] [Abstract][Full Text] [Related]
16. Patients with atrial fibrillation have nearly twice the risk of stroke in first 30 days of starting warfarin. Mayor S BMJ; 2013 Dec; 347():f7674. PubMed ID: 24368728 [No Abstract] [Full Text] [Related]
17. Atrial fibrillation and stroke management: present and future. Holmes DR Semin Neurol; 2010 Nov; 30(5):528-36. PubMed ID: 21207345 [TBL] [Abstract][Full Text] [Related]
18. Alternatives to warfarin in atrial fibrillation: drugs and devices. Bayard YL; Ostermayer SH; Sievert H Heart; 2008 Sep; 94(9):1113-6. PubMed ID: 18703688 [No Abstract] [Full Text] [Related]
19. The need for new oral anticoagulants in clinical practice. Hylek EM J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764 [TBL] [Abstract][Full Text] [Related]
20. Is it time to abandon warfarin and embrace oral direct thrombin inhibitors to prevent stroke in patients with atrial fibrillation? Rahme RJ; Bernstein R; Batjer HH; Bendok BR Neurosurgery; 2011 Feb; 68(2):N16-7. PubMed ID: 21654569 [No Abstract] [Full Text] [Related] [Next] [New Search]